Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.    COM   CA14159U3010

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
05/19/2015 05/20/2015 05/21/2015 05/22/2015 05/25/2015 Date
11.28 11.31 11.21 11.5 10.68 Last
3400 558 4330 1670 678 Volume
+0.80% +0.27% -0.88% +2.59% -7.13% Change
Financials ( CAD)
Sales 2015 42,2 M
EBIT 2015 -12,3 M
Net income 2015 -0,67 M
Debt 2015 -
Yield 2015 -
Sales 2016 54,0 M
EBIT 2016 -7,29 M
Net income 2016 6,66 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 4,26x
Capi. / Sales 2016 3,32x
Capitalization 180 M
More Financials
Company
Cardiome Pharma Corp. is a specialty pharmaceutical company, which engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.Cardiome has two marketed, in-hospital, cardiology products, BRINAVESS,... 
Sector
Pharmaceuticals
Calendar
06/22Shareholder meeting
More about the company
Surperformance© ratings of Cardiome Pharma Corp.
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP.
05/13 CARDIOME PHARMA : Reports First Quarter 2015 Financial Results
05/12 CARDIOME PHARMA : and AOP Orphan Pharma Enter ESMOCARD Commercialization Agreeme..
05/07 CARDIOME PHARMA : To Hold First Quarter 2015 Financial Results Conference Call O..
04/27 CARDIOME PHARMA : to Present at Bloom Burton & Co. Healthcare Investor Conferenc..
04/09 CARDIOME PHARMA : Receives BRINAVESS Reimbursement Approval From Belgian Authori..
03/12 CARDIOME PHARMA : reports fourth quarter and full year 2014 financial results
03/05 CARDIOME PHARMA : to Hold Fourth Quarter and Full Year 2014 Financial Results Co..
2014 CARDIOME PHARMA : Enters Development And Commercialization Agreement With Edding..
More news
Sector news : Biopharmaceuticals
04:31a AstraZeneca hit after psoriasis drug linked to suicide fears
03:45a ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 62KB)
03:20a SHIRE : New Shire research to be presented at World Congress on ADHD highlights ..
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/13 Cardiome Pharma's (CRME) CEO William Hunter on Q1 2015 Results - Earnings Cal..
05/13 Cardiome Pharma reports Q1 results
05/13 Cardiome Pharma beats by $0.07, misses on revenue
05/12 Notable earnings before Wednesday's open
03/12 Cardiome Pharma's (CRME) CEO William Hunter on Q4 2014 Results - Earnings Cal..


Comments 
Advertisement
Chart CARDIOME PHARMA CORP.
Duration : Period :
Cardiome Pharma Corp. Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions